Revolution Medicines, Inc.
Revolution Medicines, Inc.（RVMD）内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。
SEC EDGAR · FMP · RVMD · 截至 2026年6月9日
活动摘要
买入笔数
0
P-Purchase only
卖出笔数
65
近12个月
买卖比
0.00
Buy/Sell (by trades)
整体情绪
Revolution Medicines, Inc.内部人在过去近12个月主要在卖出股份，卖出行为通常由预设的Rule 10b5-1计划驱动，不一定代表对公司的负面看法。
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月9日
RVMD 季度内部人买卖趋势
RVMD 内幕交易卖出 · RVMD 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 9, 2026
活跃内部人
近12个月交易最活跃 · RVMD CEO内幕交易
显示全部内部人 · 点击卡片过滤下方交易表
▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API
近期内幕交易记录
RVMD 高管卖出股份 · RVMD 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| May 26, 2026 | Mancini Anthony See Remarks | Option | 3,121 | $105K | Form 4 |
| May 26, 2026 | Mancini Anthony See Remarks | Sale | 700 | $107K | Form 4 |
| May 26, 2026 | Mancini Anthony See Remarks | Sale | 2,000 | $308K | Form 4 |
| May 26, 2026 | Mancini Anthony See Remarks | Sale | 421 | $65K | Form 4 |
| Apr 27, 2026 | Mancini Anthony See Remarks | Option | 3,120 | $105K | Form 4 |
| Apr 27, 2026 | Mancini Anthony See Remarks | Sale | 1,671 | $220K | Form 4 |
| Apr 27, 2026 | Mancini Anthony See Remarks | Sale | 1,049 | $139K | Form 4 |
| Apr 27, 2026 | Mancini Anthony See Remarks | Sale | 400 | $54K | Form 4 |
| Apr 15, 2026 | GOLDSMITH MARK A See Remarks · Director | Option | 96,756 | $458K | Form 4 |
| Apr 15, 2026 | GOLDSMITH MARK A See Remarks · Director | Option | 23,244 | $95K | Form 4 |
| Apr 15, 2026 | GOLDSMITH MARK A See Remarks · Director | Sale | 120,000 | $18.01M⚡ | Form 4 |
| Mar 25, 2026 | Mancini Anthony See Remarks | Option | 37,450 | $1.26M⚡ | Form 4 |
| Mar 25, 2026 | Mancini Anthony See Remarks | Sale | 1,800 | $168K | Form 4 |
| Mar 25, 2026 | Mancini Anthony See Remarks | Sale | 3,128 | $295K | Form 4 |
| Mar 25, 2026 | Mancini Anthony See Remarks | Sale | 21,086 | $2.01M⚡ | Form 4 |
| Mar 25, 2026 | Mancini Anthony See Remarks | Sale | 11,036 | $1.06M⚡ | Form 4 |
| Mar 25, 2026 | Mancini Anthony See Remarks | Sale | 400 | $39K | Form 4 |
| Mar 17, 2026 | Wei Lin Chief Medical Officer | Sale | 2,073 | $206K | Form 4 |
| Mar 17, 2026 | Kelsey Stephen Michael See Remarks | Sale | 4,302 | $428K | Form 4 |
| Mar 17, 2026 | GOLDSMITH MARK A See Remarks · Director | Sale | 12,871 | $1.28M⚡ | Form 4 |
| Mar 17, 2026 | Horn Margaret A COO | Sale | 4,583 | $456K | Form 4 |
| Mar 17, 2026 | Anders Jack CFO | Sale | 2,753 | $274K | Form 4 |
| Mar 17, 2026 | Cislini Jeff General Counsel | Sale | 1,795 | $179K | Form 4 |
| Mar 19, 2026 | Cislini Jeff General Counsel | Sale | 1,163 | $113K | Form 4 |
| Mar 17, 2026 | Wang Xiaolin See Remarks | Sale | 2,010 | $200K | Form 4 |
GOLDSMITH MARK A
See Remarks · Director
日期
Apr 15
股数
120,000
均价
$150.09
总金额
$18.01M ⚡
⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股
▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 RVMD 内幕交易
RVMD 内幕交易
Revolution Medicines, Inc.（RVMD）内幕交易数据来源于公司内部人（包括GOLDSMITH MARK A (See Remarks · Director), Mancini Anthony (See Remarks), Horn Margaret A (COO)）提交的SEC Form 4申报文件。过去12个月内，5位内部人向SEC提交了交易申报。RVMD内部人近期主要在卖出，这可能反映预设的10b5-1计划执行，而非方向性判断。
如需查看Revolution Medicines, Inc.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →
常见问题
RVMD 内幕交易 · 5个问题Revolution Medicines, Inc.（RVMD）的内部人包括高管和董事，如GOLDSMITH MARK A (See Remarks · Director), Mancini Anthony (See Remarks), Horn Margaret A (COO)等。过去12个月内，5位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 9, 2026